nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—bipolar disorder	0.877	1	CbGaD
Cyclobenzaprine—HTR2A—locus ceruleus—bipolar disorder	0.0154	0.191	CbGeAlD
Cyclobenzaprine—CYP1A2—urine—bipolar disorder	0.00851	0.106	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—bipolar disorder	0.00816	0.102	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalic ventricle—bipolar disorder	0.00729	0.0907	CbGeAlD
Cyclobenzaprine—HTR2A—urine—bipolar disorder	0.00665	0.0828	CbGeAlD
Cyclobenzaprine—CYP3A4—urine—bipolar disorder	0.00616	0.0767	CbGeAlD
Cyclobenzaprine—CYP2D6—urine—bipolar disorder	0.00606	0.0754	CbGeAlD
Cyclobenzaprine—CYP1A2—blood plasma—bipolar disorder	0.00444	0.0553	CbGeAlD
Cyclobenzaprine—HTR2A—blood plasma—bipolar disorder	0.00347	0.0432	CbGeAlD
Cyclobenzaprine—CYP3A4—blood plasma—bipolar disorder	0.00321	0.04	CbGeAlD
Cyclobenzaprine—CYP2D6—blood plasma—bipolar disorder	0.00316	0.0394	CbGeAlD
Cyclobenzaprine—Olopatadine—S100B—bipolar disorder	0.00224	0.162	CrCbGaD
Cyclobenzaprine—CYP1A2—thyroid gland—bipolar disorder	0.00157	0.0195	CbGeAlD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR1A—bipolar disorder	0.00129	0.045	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C4—bipolar disorder	0.00128	0.0448	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR2C—bipolar disorder	0.00124	0.0435	CbGpPWpGaD
Cyclobenzaprine—HTR2A—nervous system—bipolar disorder	0.00103	0.0129	CbGeAlD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—DRD5—bipolar disorder	0.000983	0.0344	CbGpPWpGaD
Cyclobenzaprine—HTR2A—cerebellum—bipolar disorder	0.000972	0.0121	CbGeAlD
Cyclobenzaprine—CYP3A4—nervous system—bipolar disorder	0.000956	0.0119	CbGeAlD
Cyclobenzaprine—CYP2D6—nervous system—bipolar disorder	0.000941	0.0117	CbGeAlD
Cyclobenzaprine—CYP2D6—cerebellum—bipolar disorder	0.000885	0.011	CbGeAlD
Cyclobenzaprine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2C—bipolar disorder	0.000826	0.0289	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD5—bipolar disorder	0.000826	0.0289	CbGpPWpGaD
Cyclobenzaprine—Orphenadrine—GRIN1—bipolar disorder	0.000802	0.0581	CrCbGaD
Cyclobenzaprine—Amitriptyline—NTRK2—bipolar disorder	0.000801	0.058	CrCbGaD
Cyclobenzaprine—HTR2A—brain—bipolar disorder	0.000789	0.00982	CbGeAlD
Cyclobenzaprine—CYP2D6—brain—bipolar disorder	0.000719	0.00895	CbGeAlD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR1A—bipolar disorder	0.000573	0.02	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR2C—bipolar disorder	0.000554	0.0194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—DRD1—bipolar disorder	0.000554	0.0194	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Methylation—COMT—bipolar disorder	0.000548	0.0192	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.00054	0.0189	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—DRD3—bipolar disorder	0.000536	0.0188	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—DRD4—bipolar disorder	0.00052	0.0182	CbGpPWpGaD
Cyclobenzaprine—Protriptyline—SLC6A4—bipolar disorder	0.00052	0.0376	CrCbGaD
Cyclobenzaprine—Amitriptyline—NTRK1—bipolar disorder	0.000495	0.0358	CrCbGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—DRD2—bipolar disorder	0.000485	0.017	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.000482	0.0169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.000476	0.0167	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000467	0.0163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD1—bipolar disorder	0.000465	0.0163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.000465	0.0163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD3—bipolar disorder	0.000451	0.0158	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD4—bipolar disorder	0.000438	0.0153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—DRD2—bipolar disorder	0.000408	0.0143	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000396	0.0138	CbGpPWpGaD
Cyclobenzaprine—Cyproheptadine—HTR2C—bipolar disorder	0.000355	0.0257	CrCbGaD
Cyclobenzaprine—Cyproheptadine—HTR1A—bipolar disorder	0.000344	0.0249	CrCbGaD
Cyclobenzaprine—CYP1A2—Estrogen metabolism—COMT—bipolar disorder	0.000342	0.012	CbGpPWpGaD
Cyclobenzaprine—Benzphetamine—SLC6A3—bipolar disorder	0.000307	0.0223	CrCbGaD
Cyclobenzaprine—Cyproheptadine—DRD2—bipolar disorder	0.000292	0.0212	CrCbGaD
Cyclobenzaprine—Chlorprothixene—DRD3—bipolar disorder	0.000292	0.0211	CrCbGaD
Cyclobenzaprine—Chlorprothixene—DRD1—bipolar disorder	0.000286	0.0207	CrCbGaD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000274	0.00958	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—DGKH—bipolar disorder	0.000268	0.00938	CbGpPWpGaD
Cyclobenzaprine—Promazine—DRD4—bipolar disorder	0.000265	0.0192	CrCbGaD
Cyclobenzaprine—CYP3A4—Estrogen metabolism—COMT—bipolar disorder	0.000264	0.00924	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—SLC6A3—bipolar disorder	0.000251	0.0182	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2C—bipolar disorder	0.000245	0.0177	CrCbGaD
Cyclobenzaprine—Nortriptyline—HTR2C—bipolar disorder	0.00024	0.0174	CrCbGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00024	0.00839	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—DRD3—bipolar disorder	0.000238	0.00833	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—HTR1A—bipolar disorder	0.000233	0.0169	CrCbGaD
Cyclobenzaprine—CYP1A2—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000232	0.00811	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—DRD4—bipolar disorder	0.000231	0.00809	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—HTR2C—bipolar disorder	0.000226	0.0164	CrCbGaD
Cyclobenzaprine—Cyproheptadine—HTR2A—bipolar disorder	0.000226	0.0164	CrCbGaD
Cyclobenzaprine—Promazine—DRD1—bipolar disorder	0.000224	0.0162	CrCbGaD
Cyclobenzaprine—Trimipramine—HTR1A—bipolar disorder	0.00022	0.0159	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000219	0.00768	CbGpPWpGaD
Cyclobenzaprine—Doxepin—HTR2C—bipolar disorder	0.000216	0.0156	CrCbGaD
Cyclobenzaprine—Doxepin—HTR1A—bipolar disorder	0.000209	0.0152	CrCbGaD
Cyclobenzaprine—Chlorprothixene—DRD2—bipolar disorder	0.000202	0.0146	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.0002	0.00699	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.0002	0.00699	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—SLC6A4—bipolar disorder	0.000199	0.0144	CrCbGaD
Cyclobenzaprine—Amitriptyline—DRD3—bipolar disorder	0.000199	0.0144	CrCbGaD
Cyclobenzaprine—Nortriptyline—DRD2—bipolar disorder	0.000198	0.0143	CrCbGaD
Cyclobenzaprine—Promazine—HTR2C—bipolar disorder	0.000192	0.0139	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00019	0.00663	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—SLC6A4—bipolar disorder	0.000188	0.0136	CrCbGaD
Cyclobenzaprine—Trimipramine—DRD2—bipolar disorder	0.000186	0.0135	CrCbGaD
Cyclobenzaprine—Imipramine—SLC6A3—bipolar disorder	0.000186	0.0135	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—TRPC3—bipolar disorder	0.000186	0.0065	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000182	0.00637	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00018	0.00629	CbGpPWpGaD
Cyclobenzaprine—Promethazine—DRD2—bipolar disorder	0.00018	0.013	CrCbGaD
Cyclobenzaprine—Doxepin—SLC6A4—bipolar disorder	0.000179	0.0129	CrCbGaD
Cyclobenzaprine—Doxepin—DRD2—bipolar disorder	0.000178	0.0129	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—TACR1—bipolar disorder	0.000173	0.00605	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR2C—bipolar disorder	0.000168	0.0122	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2C—bipolar disorder	0.000167	0.0121	CrCbGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.000166	0.00582	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000165	0.00579	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR1A—bipolar disorder	0.000163	0.0118	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000163	0.0057	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.000162	0.00568	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—HTR1A—bipolar disorder	0.000162	0.0117	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00016	0.00559	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00016	0.00559	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00016	0.00559	CbGpPWpGaD
Cyclobenzaprine—Promazine—DRD2—bipolar disorder	0.000158	0.0114	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2A—bipolar disorder	0.000156	0.0113	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000155	0.00544	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.000155	0.00541	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000154	0.0054	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—HTR2A—bipolar disorder	0.000153	0.0111	CrCbGaD
Cyclobenzaprine—CYP1A2—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000152	0.00533	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—HTR2A—bipolar disorder	0.000144	0.0104	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—TAC1—bipolar disorder	0.000141	0.00493	CbGpPWpGaD
Cyclobenzaprine—Imipramine—SLC6A4—bipolar disorder	0.000139	0.0101	CrCbGaD
Cyclobenzaprine—Promethazine—HTR2A—bipolar disorder	0.000139	0.01	CrCbGaD
Cyclobenzaprine—Imipramine—DRD2—bipolar disorder	0.000138	0.01	CrCbGaD
Cyclobenzaprine—Amitriptyline—SLC6A4—bipolar disorder	0.000138	0.01	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—HTR2C—bipolar disorder	0.000138	0.00483	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—DRD2—bipolar disorder	0.000137	0.00995	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—bipolar disorder	0.000137	0.00994	CrCbGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.000126	0.00441	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000124	0.00434	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD5—bipolar disorder	0.000124	0.00433	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.000124	0.00432	CbGpPWpGaD
Cyclobenzaprine—Promazine—HTR2A—bipolar disorder	0.000122	0.00884	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00012	0.00421	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000119	0.00417	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000116	0.00406	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.000114	0.004	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.000114	0.004	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000111	0.00387	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR2A—bipolar disorder	0.000107	0.00774	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000107	0.00374	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000107	0.00374	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—HTR2A—bipolar disorder	0.000106	0.00769	CrCbGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000105	0.00368	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000103	0.00362	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000102	0.00358	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.0001	0.00351	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	9.97e-05	0.00349	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—COMT—bipolar disorder	9.61e-05	0.00336	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	9.48e-05	0.00331	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	9.36e-05	0.00327	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	9.33e-05	0.00326	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	9.15e-05	0.0032	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	9.15e-05	0.0032	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—ADM—bipolar disorder	8.95e-05	0.00313	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	8.86e-05	0.0031	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—TSHB—bipolar disorder	8.72e-05	0.00305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—TACR1—bipolar disorder	8.72e-05	0.00305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	8.61e-05	0.00301	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	8.44e-05	0.00295	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	8.11e-05	0.00284	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.08e-05	0.00283	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	8.02e-05	0.0028	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	7.75e-05	0.00271	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DGKH—bipolar disorder	7.65e-05	0.00267	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR1A—bipolar disorder	7.22e-05	0.00252	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—TAC1—bipolar disorder	7.11e-05	0.00249	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD5—bipolar disorder	6.99e-05	0.00245	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR2C—bipolar disorder	6.97e-05	0.00244	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD1—bipolar disorder	6.97e-05	0.00244	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DGKH—bipolar disorder	6.94e-05	0.00243	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—RGS4—bipolar disorder	6.86e-05	0.0024	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	6.84e-05	0.00239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD3—bipolar disorder	6.75e-05	0.00236	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—COMT—bipolar disorder	6.64e-05	0.00232	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—MAOA—bipolar disorder	6.59e-05	0.00231	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD4—bipolar disorder	6.55e-05	0.00229	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	6.55e-05	0.00229	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	6.52e-05	0.00228	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD5—bipolar disorder	6.35e-05	0.00222	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—RGS4—bipolar disorder	6.23e-05	0.00218	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD2—bipolar disorder	6.1e-05	0.00214	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	6.01e-05	0.0021	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	5.81e-05	0.00203	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—IMPA2—bipolar disorder	5.68e-05	0.00199	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—COMT—bipolar disorder	5.62e-05	0.00197	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—MAOA—bipolar disorder	5.58e-05	0.00195	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	5.55e-05	0.00194	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	5.4e-05	0.00189	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TRPC3—bipolar disorder	5.3e-05	0.00185	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	5.28e-05	0.00185	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADM—bipolar disorder	5.06e-05	0.00177	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TSHB—bipolar disorder	4.93e-05	0.00172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TACR1—bipolar disorder	4.93e-05	0.00172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PDE4B—bipolar disorder	4.93e-05	0.00172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TRPC3—bipolar disorder	4.81e-05	0.00168	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—IMPA2—bipolar disorder	4.81e-05	0.00168	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADM—bipolar disorder	4.59e-05	0.00161	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.48e-05	0.00157	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TSHB—bipolar disorder	4.47e-05	0.00156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PDE4B—bipolar disorder	4.47e-05	0.00156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TACR1—bipolar disorder	4.47e-05	0.00156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKR1C4—bipolar disorder	4.46e-05	0.00156	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—COMT—bipolar disorder	4.34e-05	0.00152	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—MAOA—bipolar disorder	4.31e-05	0.00151	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—POMC—bipolar disorder	4.29e-05	0.0015	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	4.28e-05	0.0015	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DGKH—bipolar disorder	4.1e-05	0.00143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1A—bipolar disorder	4.08e-05	0.00143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TAC1—bipolar disorder	4.02e-05	0.0014	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD1—bipolar disorder	3.94e-05	0.00138	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR2C—bipolar disorder	3.94e-05	0.00138	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—IMPA1—bipolar disorder	3.84e-05	0.00134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD3—bipolar disorder	3.81e-05	0.00133	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD5—bipolar disorder	3.75e-05	0.00131	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.71e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1A—bipolar disorder	3.7e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD4—bipolar disorder	3.7e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RGS4—bipolar disorder	3.68e-05	0.00129	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	3.66e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TAC1—bipolar disorder	3.65e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—POMC—bipolar disorder	3.64e-05	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD1—bipolar disorder	3.58e-05	0.00125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR2C—bipolar disorder	3.58e-05	0.00125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADCY2—bipolar disorder	3.49e-05	0.00122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD3—bipolar disorder	3.46e-05	0.00121	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD2—bipolar disorder	3.45e-05	0.00121	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—POMC—bipolar disorder	3.41e-05	0.00119	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD4—bipolar disorder	3.36e-05	0.00118	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	3.26e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—IMPA1—bipolar disorder	3.25e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	3.18e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADCY2—bipolar disorder	3.17e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	3.16e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD2—bipolar disorder	3.13e-05	0.0011	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TRPC3—bipolar disorder	2.84e-05	0.000994	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NR1D1—bipolar disorder	2.84e-05	0.000993	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.81e-05	0.000981	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	2.76e-05	0.000967	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NCAN—bipolar disorder	2.71e-05	0.00095	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADM—bipolar disorder	2.71e-05	0.000949	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	2.68e-05	0.000936	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	2.66e-05	0.00093	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	2.64e-05	0.000924	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TSHB—bipolar disorder	2.64e-05	0.000924	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TACR1—bipolar disorder	2.64e-05	0.000924	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.51e-05	0.000878	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NR1D1—bipolar disorder	2.4e-05	0.000841	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NCAN—bipolar disorder	2.3e-05	0.000804	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	2.25e-05	0.000788	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	2.19e-05	0.000765	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TAC1—bipolar disorder	2.15e-05	0.000754	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.13e-05	0.000746	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD1—bipolar disorder	2.11e-05	0.000739	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	2.11e-05	0.000739	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.07e-05	0.000723	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	2.06e-05	0.000719	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD3—bipolar disorder	2.05e-05	0.000716	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	2.04e-05	0.000713	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.99e-05	0.000695	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.93e-05	0.000675	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.92e-05	0.000673	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TSHB—bipolar disorder	1.87e-05	0.000655	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.87e-05	0.000655	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TPH2—bipolar disorder	1.87e-05	0.000655	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.87e-05	0.000654	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.86e-05	0.000652	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.86e-05	0.000649	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.85e-05	0.000647	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—DPYD—bipolar disorder	1.84e-05	0.000645	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NCAN—bipolar disorder	1.77e-05	0.000621	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	1.75e-05	0.000613	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.74e-05	0.000608	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.71e-05	0.000599	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	1.68e-05	0.000586	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.67e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CLOCK—bipolar disorder	1.63e-05	0.00057	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—S100B—bipolar disorder	1.63e-05	0.00057	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TSHB—bipolar disorder	1.59e-05	0.000555	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TPH2—bipolar disorder	1.59e-05	0.000555	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CACNB2—bipolar disorder	1.59e-05	0.000555	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—DPYD—bipolar disorder	1.56e-05	0.000546	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.5e-05	0.000524	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	1.45e-05	0.000508	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	1.44e-05	0.000503	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	1.41e-05	0.000495	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.4e-05	0.000488	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.33e-05	0.000464	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SNAP25—bipolar disorder	1.27e-05	0.000444	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.26e-05	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TSHB—bipolar disorder	1.23e-05	0.000429	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TPH2—bipolar disorder	1.23e-05	0.000429	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.23e-05	0.000429	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—DPYD—bipolar disorder	1.21e-05	0.000422	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—COMT—bipolar disorder	1.14e-05	0.000397	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MAOA—bipolar disorder	1.13e-05	0.000394	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ADCY2—bipolar disorder	1.12e-05	0.000393	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.12e-05	0.000392	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.09e-05	0.000382	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	1.04e-05	0.000365	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—POMC—bipolar disorder	1.04e-05	0.000362	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—bipolar disorder	1.03e-05	0.00036	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SNAP25—bipolar disorder	9.79e-06	0.000343	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—COMT—bipolar disorder	9.62e-06	0.000336	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MAOA—bipolar disorder	9.55e-06	0.000334	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—bipolar disorder	9.18e-06	0.000321	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ADCY2—bipolar disorder	8.67e-06	0.000303	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—bipolar disorder	7.77e-06	0.000272	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—COMT—bipolar disorder	7.42e-06	0.00026	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MAOA—bipolar disorder	7.37e-06	0.000258	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—POMC—bipolar disorder	7.34e-06	0.000257	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—bipolar disorder	7.3e-06	0.000255	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—POMC—bipolar disorder	6.22e-06	0.000217	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—bipolar disorder	6.18e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—bipolar disorder	6e-06	0.00021	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—POMC—bipolar disorder	4.8e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—bipolar disorder	4.77e-06	0.000167	CbGpPWpGaD
